Given the importance of TXNIP’s role in the regulation of immune inflammation and the maintenance of mitochondrial function, we suspected that TXNIP and IL-17A synergistically participate in the modulation of the microglial phenotype under pathologically high intraocular pressure (IOP), as in the context of glaucoma. This evidence concerns the gene IL17A and glaucoma.